NCT03004222View on ClinicalTrials.gov

A Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine

NACompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Laparoscopic Appendectomy
Interventions
DRUG

Bupivacaine

20 ml of 0.5% Bupivacaine

DRUG

Placebos

Trial Locations (1)

49519

Metro Health Hospital, Wyoming

Sponsors
All Listed Sponsors
lead

Metro Health, Michigan

OTHER